Back

Controversies in heart failure - Conclusion

27 August 2016 (12:25 - 12:30)
Organised by:
Congress Presentation Part of: Controversies in heart failure Pathophysiology and diagnosis ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

5 More presentations in this session

Presentation thumbnail
Controversies in heart failure - Introduction to the session
Doctor C. Yancy (Chicago, US)
Slides Video
Presentation thumbnail
ACE - inhibitors should be replaced by LCZ696 as first line therapy for heart failure - PRO
Professor J. McMurray (Glasgow, GB)
Presentation thumbnail
ACE - inhibitors should be replaced by LCZ696 as first line therapy for heart failure - CON
Professor G. Rosano (London, GB)
Slides Video
Presentation thumbnail
B-Blockers and digoxin should be forgotten in atrial fibrillation heart failure - PRO
Professor S. Hohnloser (Frankfurt, DE)
Slides Video
Presentation thumbnail
B-Blockers and digoxin should be forgotten in atrial fibrillation heart failure - CON
Professor J. Bauersachs (Hannover, DE)
Slides Video

Access the full session

Session thumbnail
Controversies in heart failure

The Event

Event poster

ESC Congress 2016

27 August 2016 12:25 CET
You may be interested in
thumbnail
Congress Session
Case-based discussion: device therapy in heart failure
17 May 2025
thumbnail
Congress Session
HFA clinical trial course in a nutshell
17 May 2025
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025
thumbnail
Congress Session
Great Debate: 'inotropes' for the treatment of heart failure remain dead and buried!
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources